We are a science led probiotic company and we develop best in class, clinically supported healthcare and nutritional products for consumers and partners worldwide.
PAtents: 250 +
Market Leading ProbIotic Cultures
35624® for management of symptoms including bloating & gas, abdominal pain, unpredictable diarrohea and constipation. Now the No 1 recommended probiotic by US Gastroenterologists and Doctors*. Manages all cardinal symptoms of IBS. Currently commercialised as a food supplement - Alflorex® (in Europe and Latin America), Align® - by our partner P&G in North America and Australia.
One of the first probiotics clinically proven to reduce levels of the stress hormone, cortisol.***. With growing interest in the potential of the gut-brain axis and 'psychobiotics', the 1714 culture has demonstrated ground breaking clinical activity (ENCK?) and safety. It is currently commercialised as a food supplement in Europe, Zenflore®.
1999: Founded as an R&D company
2009: P&G launch Align containing our bifidobacterium longum 35624 culture
2014 - current: Launch of 35624 in Ireland and subsequently in EU and Latin America
2018: Launch of Zenflore in Europe containing our 1714-Serenitas culture